1. Home
  2. LFCR vs EHAB Comparison

LFCR vs EHAB Comparison

Compare LFCR & EHAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LFCR
  • EHAB
  • Stock Information
  • Founded
  • LFCR 1986
  • EHAB 2014
  • Country
  • LFCR United States
  • EHAB United States
  • Employees
  • LFCR N/A
  • EHAB N/A
  • Industry
  • LFCR Biotechnology: Pharmaceutical Preparations
  • EHAB Hospital/Nursing Management
  • Sector
  • LFCR Health Care
  • EHAB Health Care
  • Exchange
  • LFCR Nasdaq
  • EHAB Nasdaq
  • Market Cap
  • LFCR 308.8M
  • EHAB 330.2M
  • IPO Year
  • LFCR N/A
  • EHAB N/A
  • Fundamental
  • Price
  • LFCR $7.37
  • EHAB $7.55
  • Analyst Decision
  • LFCR Buy
  • EHAB Buy
  • Analyst Count
  • LFCR 4
  • EHAB 3
  • Target Price
  • LFCR $8.00
  • EHAB $8.67
  • AVG Volume (30 Days)
  • LFCR 125.1K
  • EHAB 602.7K
  • Earning Date
  • LFCR 08-07-2025
  • EHAB 08-06-2025
  • Dividend Yield
  • LFCR N/A
  • EHAB N/A
  • EPS Growth
  • LFCR N/A
  • EHAB N/A
  • EPS
  • LFCR N/A
  • EHAB N/A
  • Revenue
  • LFCR $128,867,000.00
  • EHAB $1,037,800,000.00
  • Revenue This Year
  • LFCR $4.10
  • EHAB $4.66
  • Revenue Next Year
  • LFCR $14.29
  • EHAB $4.99
  • P/E Ratio
  • LFCR N/A
  • EHAB N/A
  • Revenue Growth
  • LFCR 0.47
  • EHAB N/A
  • 52 Week Low
  • LFCR $3.68
  • EHAB $6.47
  • 52 Week High
  • LFCR $8.85
  • EHAB $10.91
  • Technical
  • Relative Strength Index (RSI)
  • LFCR 47.91
  • EHAB 53.74
  • Support Level
  • LFCR $7.03
  • EHAB $7.32
  • Resistance Level
  • LFCR $7.87
  • EHAB $7.78
  • Average True Range (ATR)
  • LFCR 0.40
  • EHAB 0.31
  • MACD
  • LFCR 0.01
  • EHAB 0.16
  • Stochastic Oscillator
  • LFCR 53.70
  • EHAB 72.14

About LFCR Lifecore Biomedical Inc.

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.

About EHAB Enhabit Inc.

Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services for adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing a life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.

Share on Social Networks: